170 related articles for article (PubMed ID: 18825277)
1. EGFR expression in gallbladder carcinoma in North America.
Kaufman M; Mehrotra B; Limaye S; White S; Fuchs A; Lebowicz Y; Nissel-Horowitz S; Thomas A
Int J Med Sci; 2008 Sep; 5(5):285-91. PubMed ID: 18825277
[TBL] [Abstract][Full Text] [Related]
2. Expression of Human Epidermal Growth Factor Receptor (Her 2/neu) and Proliferative Marker Ki-67: Association with Clinicopathological Parameters in Gallbladder Carcinoma.
Pujani M; Makker I; Makker A; Jetley S; Goel MM; Jetley S
Asian Pac J Cancer Prev; 2016; 17(8):3903-9. PubMed ID: 27644637
[TBL] [Abstract][Full Text] [Related]
3. EGFR Expression in Gallbladder Carcinoma in North Indian Population.
Vikash ; Kailashiya V; Kumar M; Puneet
Gulf J Oncolog; 2023 May; 1(42):47-52. PubMed ID: 37283260
[TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor receptor and HER-2/neu status by immunohistochemistry and fluorescence in situ hybridization in adenocarcinomas of the biliary tree and gallbladder.
Shafizadeh N; Grenert JP; Sahai V; Kakar S
Hum Pathol; 2010 Apr; 41(4):485-92. PubMed ID: 20040392
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic significance of EGFR and Her-2/neu in colorectal adenocarcinomas.
Kountourakis P; Pavlakis K; Psyrri A; Rontogianni D; Xiros N; Patsouris E; Pectasides D; Economopoulos T
Cancer J; 2006; 12(3):229-36. PubMed ID: 16803682
[TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor receptor expression in carcinoma gallbladder: A prospective study in Indian scenario.
Kumar N; Khan MA; Kumar N; ; Ranjan R; Hazra N
J Cancer Res Ther; 2016; 12(2):959-62. PubMed ID: 27461681
[TBL] [Abstract][Full Text] [Related]
7. EGFR and HER-2/neu Expression in Gallbladder Carcinoma: An Institutional Experience.
Hadi R; Pant MC; Husain N; Singhal A; Khurana R; Agarwal GR; Masood S; Awashthi NP
Gulf J Oncolog; 2016 Jan; 1(20):12-9. PubMed ID: 27050174
[TBL] [Abstract][Full Text] [Related]
8. ERBB2 and KRAS alterations mediate response to EGFR inhibitors in early stage gallbladder cancer.
Iyer P; Shrikhande SV; Ranjan M; Joshi A; Gardi N; Prasad R; Dharavath B; Thorat R; Salunkhe S; Sahoo B; Chandrani P; Kore H; Mohanty B; Chaudhari V; Choughule A; Kawle D; Chaudhari P; Ingle A; Banavali S; Gera P; Ramadwar MR; Prabhash K; Barreto SG; Dutt S; Dutt A
Int J Cancer; 2019 Apr; 144(8):2008-2019. PubMed ID: 30304546
[TBL] [Abstract][Full Text] [Related]
9. Expression of the c-erb-B2 and p53 protein in gallbladder carcinomas.
Kim YW; Huh SH; Park YK; Yoon TY; Lee SM; Hong SH
Oncol Rep; 2001; 8(5):1127-32. PubMed ID: 11496329
[TBL] [Abstract][Full Text] [Related]
10. Expression of HER-2/neu, epidermal growth factor receptor, vascular endothelial growth factor, cyclooxygenase-2, estrogen receptor, and progesterone receptor in small cell and large cell neuroendocrine carcinoma of the uterine cervix: a clinicopathologic and prognostic study.
Tangjitgamol S; Ramirez PT; Sun CC; See HT; Jhingran A; Kavanagh JJ; Deavers MT
Int J Gynecol Cancer; 2005; 15(4):646-56. PubMed ID: 16014119
[TBL] [Abstract][Full Text] [Related]
11. Human epidermal growth factor receptor-2 family in colorectal adenocarcinoma: correlation with survival and clinicopathological findings.
Molaei M; Pejhan S; Nayer BN; Moradi A; Ghiasi S; Zali MR
Eur J Gastroenterol Hepatol; 2009 Mar; 21(3):289-93. PubMed ID: 19279475
[TBL] [Abstract][Full Text] [Related]
12. Hormone receptor, HER2/NEU and EGFR expression in ovarian carcinoma--is here a prognostic phenotype?
Demir L; Yigit S; Sadullahoglu C; Akyol M; Cokmert S; Kucukzeybek Y; Alacacioglu A; Cakalagaoglu F; Tarhan MO
Asian Pac J Cancer Prev; 2014; 15(22):9739-45. PubMed ID: 25520097
[TBL] [Abstract][Full Text] [Related]
13. Discordance between EGFR expression and clinicopathologic parameters of colorectal adenocarcinoma in Taiwan.
Tsai WC; Lin CK; Lee HS; Chen A; Nieh S; Yu CP; Wu CC; Jao SW; Jin JS
Chin J Physiol; 2012 Oct; 55(5):352-60. PubMed ID: 23282210
[TBL] [Abstract][Full Text] [Related]
14. [Clinical significance of HER2 positivity in gallbladder adenocarcinoma].
Yao JG; Wang CH; Liu Y
Zhonghua Bing Li Xue Za Zhi; 2017 Apr; 46(4):245-248. PubMed ID: 28376590
[No Abstract] [Full Text] [Related]
15. Gallbladder cancers rarely overexpress HER-2/neu, demonstrated by Hercep test.
Matsuyama S; Kitajima Y; Sumi K; Mori D; Satoh T; Miyazaki K
Oncol Rep; 2004 Apr; 11(4):815-9. PubMed ID: 15010878
[TBL] [Abstract][Full Text] [Related]
16. Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors.
Petit AM; Rak J; Hung MC; Rockwell P; Goldstein N; Fendly B; Kerbel RS
Am J Pathol; 1997 Dec; 151(6):1523-30. PubMed ID: 9403702
[TBL] [Abstract][Full Text] [Related]
17. Epidemiological study of HER-2 mutations among EGFR wild-type lung adenocarcinoma patients in China.
Li X; Zhao C; Su C; Ren S; Chen X; Zhou C
BMC Cancer; 2016 Oct; 16(1):828. PubMed ID: 27793199
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the prognostic significance of HER family mRNA expression in high-risk early breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) validation study.
Koutras A; Kalogeras KT; Wirtz RM; Alexopoulou Z; Bobos M; Zagouri F; Veltrup E; Timotheadou E; Gogas H; Pentheroudakis G; Pisanidis N; Magkou C; Christodoulou C; Bafaloukos D; Papakostas P; Aravantinos G; Pectasides D; Kalofonos HP; Fountzilas G
J Transl Med; 2015 May; 13():171. PubMed ID: 26021752
[TBL] [Abstract][Full Text] [Related]
19. Expression and Prognostic Significance of Human Epidermal Growth Factor Receptors 1, 2 and 3 in Periampullary Adenocarcinoma.
Elebro J; Heby M; Warfvinge CF; Nodin B; Eberhard J; Jirström K
PLoS One; 2016; 11(4):e0153533. PubMed ID: 27070783
[TBL] [Abstract][Full Text] [Related]
20. [Trend analysis and clinicopathological characteristics of 198 young patients with advanced lung adenocarcinoma].
Li YF; Wang Y; Li JL; Hao XZ; Hu XS; Wang HY
Zhonghua Zhong Liu Za Zhi; 2016 Oct; 38(10):750-755. PubMed ID: 27784458
[No Abstract] [Full Text] [Related]
[Next] [New Search]